ARROWHEAD PHARMACEUTICALS, INC. Stock-Based Compensation
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Stock-Based Compensation of $50.91 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-04
- ARROWHEAD PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $14.87M, a 14.02% increase year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $16.67M, a 4.01% increase year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $19.37M, a 27.37% increase year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $19.09M, a 1.99% decline year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $63.37M, a 14.33% decline from fiscal 2024.
- ARROWHEAD PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $73.97M, a 5.33% decline from fiscal 2023.
- ARROWHEAD PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $78.13M, a 35.37% decline from fiscal 2022.
- ARROWHEAD PHARMACEUTICALS, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $120.89M, a 57.67% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed | Share-based Payment Arrangement, Noncash Expense 98 month | Share-based Payment Arrangement, Noncash Expense 101 month | Share-based Payment Arrangement, Noncash Expense 104 month | Share-based Payment Arrangement, Noncash Expense 107 month | Share-based Payment Arrangement, Noncash Expense 110 month | Share-based Payment Arrangement, Noncash Expense 113 month | Share-based Payment Arrangement, Noncash Expense 116 month | Share-based Payment Arrangement, Noncash Expense 119 month | Share-based Payment Arrangement, Noncash Expense 122 month | Share-based Payment Arrangement, Noncash Expense 125 month | Share-based Payment Arrangement, Noncash Expense 128 month | Share-based Payment Arrangement, Noncash Expense 131 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $14.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-04 | $31.54M derived: sum of 2 quarters · filed 2026-08-04 | $50.91M 10-Q · filed 2026-08-04 | $70.00M derived: sum of 4 quarters · filed 2026-08-04 | ||||||||||||||||
| 2026-03-31 | $16.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-07 | $36.04M 10-Q · filed 2026-05-07 | $55.13M derived: sum of 3 quarters · filed 2026-05-07 | $68.17M derived: sum of 4 quarters · filed 2026-08-04 | ||||||||||||||||
| 2025-12-31 | $19.37M 10-Q · filed 2026-02-05 | $38.46M derived: sum of 2 quarters · filed 2026-02-05 | $51.50M derived: sum of 3 quarters · filed 2026-08-04 | $67.53M derived: sum of 4 quarters · filed 2026-08-04 | ||||||||||||||||
| 2025-09-30 | $19.09M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $32.13M derived: sum of 2 quarters · filed 2026-08-04 | $48.16M derived: sum of 3 quarters · filed 2026-08-04 | $63.37M 10-K · filed 2025-11-25 | ||||||||||||||||
| 2025-06-30 | $13.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-04 | $29.07M derived: sum of 2 quarters · filed 2026-08-04 | $44.28M 10-Q · filed 2026-08-04 | $63.75M derived: sum of 4 quarters · filed 2026-08-04 | ||||||||||||||||
| 2025-03-31 | $16.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-07 | $31.24M 10-Q · filed 2026-05-07 | $50.71M derived: sum of 3 quarters · filed 2026-05-07 | $67.76M derived: sum of 4 quarters · filed 2026-05-07 | ||||||||||||||||
| 2024-12-31 | $15.21M 10-Q · filed 2026-02-05 | $34.68M derived: sum of 2 quarters · filed 2026-02-05 | $51.73M derived: sum of 3 quarters · filed 2026-02-05 | $69.48M derived: sum of 4 quarters · filed 2026-02-05 | ||||||||||||||||
| 2024-09-30 | $19.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $36.52M derived: sum of 2 quarters · filed 2025-11-25 | $54.27M derived: sum of 3 quarters · filed 2025-11-25 | $73.97M 10-K · filed 2025-11-25 | ||||||||||||||||
| 2024-06-30 | $17.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-07 | $34.80M derived: sum of 2 quarters · filed 2025-08-07 | $54.49M 10-Q · filed 2025-08-07 | $72.67M derived: sum of 4 quarters · filed 2025-11-25 | ||||||||||||||||
| 2024-03-31 | $17.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-12 | $37.44M 10-Q · filed 2025-05-12 | $55.63M derived: sum of 3 quarters · filed 2025-11-25 | $75.57M derived: sum of 4 quarters · filed 2025-11-25 | ||||||||||||||||
| 2023-12-31 | $19.69M 10-Q · filed 2025-02-10 | $37.88M derived: sum of 2 quarters · filed 2025-11-25 | $57.82M derived: sum of 3 quarters · filed 2025-11-25 | $78.43M derived: sum of 4 quarters · filed 2025-11-25 | ||||||||||||||||
| 2023-09-30 | $18.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $38.13M derived: sum of 2 quarters · filed 2025-11-25 | $58.74M derived: sum of 3 quarters · filed 2025-11-25 | $78.13M 10-K · filed 2025-11-25 | ||||||||||||||||
| 2023-06-30 | $19.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-08 | $40.56M derived: sum of 2 quarters · filed 2024-08-08 | $59.95M 10-Q · filed 2024-08-08 | $89.14M derived: sum of 4 quarters · filed 2024-11-26 | ||||||||||||||||
| 2023-03-31 | $20.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-09 | $40.00M 10-Q · filed 2024-05-09 | $69.20M derived: sum of 3 quarters · filed 2024-11-26 | $102.59M derived: sum of 4 quarters · filed 2024-11-26 | ||||||||||||||||
| 2022-12-31 | $19.39M 10-Q · filed 2024-02-06 | $48.59M derived: sum of 2 quarters · filed 2024-11-26 | $81.98M derived: sum of 3 quarters · filed 2024-11-26 | $115.78M derived: sum of 4 quarters · filed 2024-11-26 | ||||||||||||||||
| 2022-09-30 | $29.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-26 | $62.59M derived: sum of 2 quarters · filed 2024-11-26 | $96.39M derived: sum of 3 quarters · filed 2024-11-26 | $120.89M 10-K · filed 2024-11-26 | ||||||||||||||||
| 2022-06-30 | $33.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-07 | $67.19M derived: sum of 2 quarters · filed 2023-08-07 | $91.70M 10-Q · filed 2023-08-07 | $126.32M derived: sum of 4 quarters · filed 2023-11-29 | ||||||||||||||||
| 2022-03-31 | $33.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-02 | $58.31M 10-Q · filed 2023-05-02 | $92.93M derived: sum of 3 quarters · filed 2023-11-29 | $111.48M derived: sum of 4 quarters · filed 2023-11-29 | ||||||||||||||||
| 2021-12-31 | $24.50M 10-Q · filed 2023-02-06 | $59.13M derived: sum of 2 quarters · filed 2023-11-29 | $77.67M derived: sum of 3 quarters · filed 2023-11-29 | $93.03M derived: sum of 4 quarters · filed 2023-11-29 | ||||||||||||||||
| 2021-09-30 | $34.62M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-29 | $53.17M derived: sum of 2 quarters · filed 2023-11-29 | $68.53M derived: sum of 3 quarters · filed 2023-11-29 | $76.67M 10-K · filed 2023-11-29 | ||||||||||||||||
| 2021-06-30 | $18.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-04 | $33.91M derived: sum of 2 quarters · filed 2022-08-04 | $42.05M 10-Q · filed 2022-08-04 | $57.92M derived: sum of 4 quarters · filed 2022-11-28 | ||||||||||||||||
| 2021-03-31 | $15.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-10 | $23.50M 10-Q · filed 2022-05-10 | $39.38M derived: sum of 3 quarters · filed 2022-11-28 | $49.42M derived: sum of 4 quarters · filed 2022-11-28 | ||||||||||||||||
| 2020-12-31 | $8.14M 10-Q · filed 2022-02-02 | $24.02M derived: sum of 2 quarters · filed 2022-11-28 | $34.06M derived: sum of 3 quarters · filed 2022-11-28 | $47.03M derived: sum of 4 quarters · filed 2022-11-28 | ||||||||||||||||
| 2020-09-30 | $15.87M derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-28 | $25.92M derived: sum of 2 quarters · filed 2022-11-28 | $38.89M derived: sum of 3 quarters · filed 2022-11-28 | $43.38M 10-K · filed 2022-11-28 | $43.38M 10-K · filed 2020-11-23 | |||||||||||||||
| 2020-06-30 | $10.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-05 | $23.02M derived: sum of 2 quarters · filed 2021-08-05 | $27.51M 10-Q · filed 2021-08-05 | $27.51M 10-Q · filed 2020-08-05 | $32.63M derived: sum of 4 quarters · filed 2021-11-22 | |||||||||||||||
| 2020-03-31 | $12.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-04 | $17.46M 10-Q · filed 2021-05-04 | $17.46M 10-Q · filed 2020-05-07 | $22.58M derived: sum of 3 quarters · filed 2021-11-22 | $24.54M derived: sum of 4 quarters · filed 2021-11-22 | |||||||||||||||
| 2019-12-31 | $4.49M 10-Q · filed 2021-02-04 | $4.49M 10-Q · filed 2020-02-05 | $9.61M derived: sum of 2 quarters · filed 2021-11-22 | $11.57M derived: sum of 3 quarters · filed 2021-11-22 | $14.17M derived: sum of 4 quarters · filed 2021-11-22 | |||||||||||||||
| 2019-09-30 | $5.12M derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-22 | $7.07M derived: sum of 2 quarters · filed 2021-11-22 | $9.68M derived: sum of 3 quarters · filed 2021-11-22 | $12.39M 10-K · filed 2021-11-22 | $12.39M 10-K · filed 2019-11-25 | |||||||||||||||
| 2019-06-30 | $1.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-05 | $4.56M derived: sum of 2 quarters · filed 2020-08-05 | $7.28M 10-Q · filed 2020-08-05 | $9.91M derived: sum of 4 quarters · filed 2020-11-23 | ||||||||||||||||
| 2019-03-31 | $2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-07 | $5.32M 10-Q · filed 2020-05-07 | $7.96M derived: sum of 3 quarters · filed 2020-11-23 | $10.22M derived: sum of 4 quarters · filed 2020-11-23 | ||||||||||||||||
| 2018-12-31 | $2.72M 10-Q · filed 2020-02-05 | $5.35M derived: sum of 2 quarters · filed 2020-11-23 | $7.62M derived: sum of 3 quarters · filed 2020-11-23 | $9.08M derived: sum of 4 quarters · filed 2020-11-23 | ||||||||||||||||
| 2018-09-30 | $2.64M derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-23 | $4.91M derived: sum of 2 quarters · filed 2020-11-23 | $6.36M derived: sum of 3 quarters · filed 2020-11-23 | $8.45M 10-K · filed 2020-11-23 | ||||||||||||||||
| 2018-06-30 | $2.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-05 | $3.73M derived: sum of 2 quarters · filed 2019-08-05 | $5.82M 10-Q · filed 2019-08-05 | $7.83M derived: sum of 4 quarters · filed 2019-11-25 | ||||||||||||||||
| 2018-03-31 | $1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-08 | $3.55M 10-Q · filed 2019-05-08 | $5.56M derived: sum of 3 quarters · filed 2019-11-25 | $7.27M derived: sum of 4 quarters · filed 2019-11-25 | ||||||||||||||||
| 2017-12-31 | $2.09M 10-Q · filed 2019-02-07 | $4.10M derived: sum of 2 quarters · filed 2019-11-25 | $5.82M derived: sum of 3 quarters · filed 2019-11-25 | $7.56M derived: sum of 4 quarters · filed 2019-11-25 | ||||||||||||||||
| 2017-09-30 | $2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-25 | $3.72M derived: sum of 2 quarters · filed 2019-11-25 | $5.47M derived: sum of 3 quarters · filed 2019-11-25 | $7.89M 10-K · filed 2019-11-25 | ||||||||||||||||
| 2017-06-30 | $1.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-07 | $3.46M derived: sum of 2 quarters · filed 2018-08-07 | $5.88M 10-Q · filed 2018-08-07 | $9.93M derived: sum of 4 quarters · filed 2018-12-11 | ||||||||||||||||
| 2017-03-31 | $1.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-08 | $4.17M 10-Q · filed 2018-05-08 | $8.22M derived: sum of 3 quarters · filed 2018-12-11 | $10.97M derived: sum of 4 quarters · filed 2018-12-11 | ||||||||||||||||
| 2016-12-31 | $2.42M 10-Q · filed 2018-02-09 | $6.47M derived: sum of 2 quarters · filed 2018-12-11 | $9.22M derived: sum of 3 quarters · filed 2018-12-11 | $11.64M derived: sum of 4 quarters · filed 2018-12-11 | ||||||||||||||||
| 2016-09-30 | $4.05M derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-11 | $6.80M derived: sum of 2 quarters · filed 2018-12-11 | $9.22M derived: sum of 3 quarters · filed 2018-12-11 | $11.60M 10-K · filed 2018-12-11 | ||||||||||||||||
| 2016-06-30 | $2.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-03 | $5.17M derived: sum of 2 quarters · filed 2017-08-03 | $7.55M 10-Q · filed 2017-08-03 | $11.07M derived: sum of 4 quarters · filed 2017-12-12 | ||||||||||||||||
| 2016-03-31 | $2.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-03 | $4.80M 10-Q · filed 2017-05-03 | $8.32M derived: sum of 3 quarters · filed 2017-12-12 | $10.81M derived: sum of 4 quarters · filed 2017-12-12 | ||||||||||||||||
| 2015-12-31 | $2.38M 10-Q · filed 2017-02-06 | $5.91M derived: sum of 2 quarters · filed 2017-12-12 | $8.39M derived: sum of 3 quarters · filed 2017-12-12 | $10.60M derived: sum of 4 quarters · filed 2017-12-12 | ||||||||||||||||
| 2015-09-30 | $3.53M derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-12 | $6.01M derived: sum of 2 quarters · filed 2017-12-12 | $8.22M derived: sum of 3 quarters · filed 2017-12-12 | $10.23M 10-K · filed 2017-12-12 | ||||||||||||||||
| 2015-06-30 | $2.49M 10-Q · filed 2015-08-04 | $4.69M derived: sum of 2 quarters · filed 2015-08-04 | $6.71M 10-Q · filed 2016-08-09 | $8.64M derived: sum of 4 quarters · filed 2016-12-14 | ||||||||||||||||
| 2015-03-31 | $2.21M 10-Q · filed 2015-05-11 | $4.22M 10-Q · filed 2016-05-10 | $6.16M derived: sum of 3 quarters · filed 2016-12-14 | $8.20M derived: sum of 4 quarters · filed 2016-12-14 | ||||||||||||||||
| 2014-12-31 | $2.01M 10-Q · filed 2016-02-09 | $3.95M derived: sum of 2 quarters · filed 2016-12-14 | $5.99M derived: sum of 3 quarters · filed 2016-12-14 | $7.19M derived: sum of 4 quarters · filed 2016-12-14 | ||||||||||||||||
| 2014-09-30 | $1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-14 | $3.98M derived: sum of 2 quarters · filed 2016-12-14 | $5.18M derived: sum of 3 quarters · filed 2016-12-14 | $5.70M 10-K · filed 2016-12-14 | ||||||||||||||||
| 2014-06-30 | $2.04M 10-Q · filed 2015-08-04 | $3.24M derived: sum of 2 quarters · filed 2015-08-04 | $3.76M 10-Q · filed 2015-08-04 | $4.18M derived: sum of 4 quarters · filed 2015-12-14 | ||||||||||||||||
| 2014-03-31 | $1.20M 10-Q · filed 2015-05-11 | $1.72M 10-Q · filed 2015-05-11 | $2.14M derived: sum of 3 quarters · filed 2015-12-14 | $2.51M derived: sum of 4 quarters · filed 2015-12-14 | $16.84M 10-Q · filed 2014-05-06 | |||||||||||||||
| 2013-12-31 | $521.14K 10-Q · filed 2015-02-09 | $943.03K derived: sum of 2 quarters · filed 2015-12-14 | $1.31M derived: sum of 3 quarters · filed 2015-12-14 | $1.66M derived: sum of 4 quarters · filed 2015-12-14 | $15.64M 10-Q · filed 2014-02-04 | |||||||||||||||
| 2013-09-30 | $421.90K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-14 | $785.49K derived: sum of 2 quarters · filed 2015-12-14 | $1.14M derived: sum of 3 quarters · filed 2015-12-14 | $1.54M 10-K · filed 2015-12-14 | $15.12M 10-K · filed 2013-12-18 | |||||||||||||||
| 2013-06-30 | $363.59K 10-Q · filed 2014-08-12 | $718.70K derived: sum of 2 quarters · filed 2014-08-12 | $1.11M 10-Q · filed 2014-08-12 | $1.52M derived: sum of 4 quarters · filed 2014-11-25 | $14.70M 10-Q · filed 2013-08-07 | |||||||||||||||
| 2013-03-31 | $355.11K 10-Q · filed 2014-05-06 | $750.78K 10-Q · filed 2014-05-06 | $1.15M derived: sum of 3 quarters · filed 2014-11-25 | $1.57M derived: sum of 4 quarters · filed 2014-11-25 | $14.33M 10-Q · filed 2013-05-09 | |||||||||||||||
| 2012-12-31 | $395.68K 10-Q · filed 2014-02-04 | $799.89K derived: sum of 2 quarters · filed 2014-11-25 | $1.22M derived: sum of 3 quarters · filed 2014-11-25 | $1.39M derived: sum of 4 quarters · filed 2014-11-25 | $13.98M 10-Q · filed 2013-02-13 | |||||||||||||||
| 2012-09-30 | $404.22K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-25 | $820.14K derived: sum of 2 quarters · filed 2014-11-25 | $989.53K derived: sum of 3 quarters · filed 2014-11-25 | $1.24M 10-K · filed 2014-11-25 | $13.58M 10-K · filed 2012-12-28 | |||||||||||||||
| 2012-06-30 | $415.92K 10-Q · filed 2013-08-07 | $585.31K derived: sum of 2 quarters · filed 2013-08-07 | $837.19K 10-Q · filed 2013-08-07 | $1.14M derived: sum of 4 quarters · filed 2013-08-07 | $13.18M 10-Q · filed 2012-08-13 | |||||||||||||||
| 2012-03-31 | $169.39K 10-Q · filed 2013-05-09 | $421.27K 10-Q · filed 2013-05-09 | $719.24K derived: sum of 3 quarters · filed 2013-05-09 | $1.07M derived: sum of 4 quarters · filed 2013-05-09 | $12.76M 10-Q · filed 2012-05-08 | |||||||||||||||
| 2011-12-31 | $251.88K 10-Q · filed 2013-02-13 | $549.85K derived: sum of 2 quarters · filed 2013-02-13 | $896.55K derived: sum of 3 quarters · filed 2013-02-13 | $1.26M derived: sum of 4 quarters · filed 2013-02-13 | $12.59M 10-Q · filed 2012-02-09 | |||||||||||||||
| 2011-09-30 | $297.97K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-28 | $644.68K derived: sum of 2 quarters · filed 2012-12-28 | $1.01M derived: sum of 3 quarters · filed 2012-12-28 | $1.38M 10-K · filed 2012-12-28 | $12.34M 10-Q · filed 2012-08-13 | |||||||||||||||
| 2011-06-30 | $346.71K 10-Q · filed 2012-08-13 | $708.80K derived: sum of 2 quarters · filed 2012-08-13 | $1.08M 10-Q · filed 2012-08-13 | $12.04M 10-Q · filed 2011-08-08 | ||||||||||||||||
| 2011-03-31 | $362.10K 10-Q · filed 2012-05-08 | $732.24K 10-Q · filed 2012-05-08 | ||||||||||||||||||
| 2010-12-31 | $370.15K 10-Q · filed 2012-02-09 | |||||||||||||||||||
| 2010-09-30 | $1.42M 10-K · filed 2011-12-20 | |||||||||||||||||||
| 2010-06-30 | $390.23K 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |